HAMMOND JANET MJ

PrivateCIK: 1829899

HAMMOND JANET MJ (Chief Development Officer) received a stock award from ATEA PHARMACEUTICALS, INC.

Compensation award — not an open‑market transaction. Less informative as a directional signal.

A · 1 award
InsiderHAMMOND JANET MJCIK 1829899
Officer· Chief Development Officer
Since Oct 2020
+208.37K
Net shares
Net buyer
$43.3K
Total sold
0
Open market trades
0B · 0S
6
Total transactions
269.30K acquired · 60.93K disposed
Non-Derivative Transactions3

Common Stock

Direct
M · Option Exercise

Shares

+46.80K

Price / share

Trade value

% of position

124.9%
1/31/2025
37.47K84.27K

Common Stock

Direct
A · Award

Shares

+11.25K

Price / share

Trade value

% of position

13.3%
1/31/2025
84.27K95.52K

Common Stock

Direct
F · Tax Withholding

Shares

14.13K

Price / share

$3.06

Trade value

$43.25K

% of position

14.8%
1/31/2025
95.52K81.39K
Total

Net shares

+43.92K

Net value

-$43.25K

Derivative Transactions3

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

46.80K shares

Shares

46.80K

Strike price

Held after

46.80K

Exercisable

1/31/2025

Restricted Stock Units

Direct
A · Award
Converts to

Common Stock

11.25K shares

Shares

+11.25K

Strike price

Held after

11.25K

Exercisable

1/31/2025

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Common Stock

200K shares

Shares

+200K

Strike price

3.06

Held after

200K

Exercisable

1/31/2025
HAMMOND JANET MJ — Insider Transaction (Form 4) Filed Feb 4, 2025 | Finecho